Sandra L. Bragg
Centers for Disease Control and Prevention
Network
Latest external collaboration on country level. Dive into details by clicking on the dots.
Publication
Featured researches published by Sandra L. Bragg.
Journal of Clinical Microbiology | 2003
Mary D. Bajani; David A. Ashford; Sandra L. Bragg; Christopher W. Woods; Tin Aye; Richard A. Spiegel; Brian D. Plikaytis; Bradley A. Perkins; Maureen Phelan; Paul N. Levett; Robbin S. Weyant
ABSTRACT Four rapid tests for the serologic diagnosis of leptospirosis were evaluated, and the performance of each was compared with that of the current standard, the microscopic agglutination test (MAT). The four rapid tests were a microplate immunoglobulin M (IgM)-enzyme-linked immunosorbent assay (ELISA), an indirect hemagglutination assay (IHA), an IgM dipstick assay (LDS), and an IgM dot-ELISA dipstick test (DST). A panel of 276 sera from 133 cases of leptospirosis from four different geographic locations was tested as well as 642 sera from normal individuals or individuals with other infectious or autoimmune diseases. Acute-phase sera from cases (n = 148) were collected ≤14 days (median = 6.0) after the onset of symptoms, and convalescent-phase sera (n = 128) were collected ≥15 days after onset (median = 29.1). By a traditional method (two-by-two contingency table), the sensitivities for detection of leptospirosis cases were 93.2% by LDS, 92.5% by DST, 86.5% by ELISA, and 79.0% by IHA. Specificity was 98.8% by DST, 97% by ELISA and MAT, 95.8% by IHA, and 89.6% by LDS. With a latent class analysis (LCA) model that included all the rapid tests and the clinical case definition, sensitivity was 95.5% by DST, 94.5% by LDS, 89.9% by ELISA, and 81.1% by IHA. The sensitivity and specificity estimated by the traditional methods were quite close to the LCA estimates. However, LCA allowed estimation of the sensitivity of the MAT (98.2%), which traditional methods do not allow. For acute-phase sera, sensitivity was 52.7% by LDS, 50.0% by DST, 48.7% by MAT and ELISA, and 38.5% by IHA. The sensitivity for convalescent-phase sera was 93.8% by MAT, 84.4% by DST, 83.6% by LDS, 75.0% by ELISA, and 67.2% by IHA. A good overall correlation with the MAT was obtained for each of the assays, with the highest concordance being with the DST (kappa value, 0.85; 95% confidence interval [CI], 0.8 to 0.90). The best correlation was between ELISA and DST (kappa value, 0.86; 95% CI, 0.81 to 0.91). False-positive LDS results were frequent (≥20%) in sera from individuals with Epstein-Barr virus, human immunodeficiency virus, and periodontal disease and from healthy volunteers. The ease of use and significantly high sensitivity and specificity of DST and ELISA make these good choices for diagnostic testing.
Clinical Infectious Diseases | 2002
Juliette Morgan; Shari L. Bornstein; Adam Karpati; Michael G. Bruce; Carole A. Bolin; Constance C. Austin; Christopher W. Woods; Jairam R. Lingappa; Carl Langkop; Belinda Davis; Donald R. Graham; Mary E. Proctor; David A. Ashford; Mary D. Bajani; Sandra L. Bragg; Kathleen A. Shutt; Bradley A. Perkins; Jordan W. Tappero
We investigated an outbreak of leptospirosis among athletes and community residents after a triathlon was held in Springfield, Illinois. A telephone survey was conducted to collect clinical information and data on possible risk factors, community surveillance was established, and animal specimens and lake water samples were collected to determine the source of the leptospiral contamination. A total of 834 of 876 triathletes were contacted; 98 (12%) reported being ill. Serum samples obtained from 474 athletes were tested; 52 of these samples (11%) tested positive for leptospirosis. Fourteen (6%) of 248 symptomatic community residents tested positive for leptospirosis. Heavy rains that preceded the triathlon are likely to have increased leptospiral contamination of Lake Springfield. Among athletes, ingestion of 1 or more swallows of lake water was a predominant risk factor for illness. This is the largest outbreak of leptospirosis that has been reported in the United States. Health care providers and occupational and recreational users of bodies of freshwater in the United States should be aware of the risk of contracting leptospirosis, particularly after heavy rains.
Emerging Infectious Diseases | 2003
James J. Sejvar; Elizabeth Bancroft; Kevin Winthrop; Julie A. Bettinger; Mary D. Bajani; Sandra L. Bragg; Kathleen A. Shutt; Robyn M. Kaiser; Nina Marano; Tanja Popovic; Jordan W. Tappero; David A. Ashford; Laurene Mascola; Duc J. Vugia; Bradley A. Perkins; Nancy E. Rosenstein
Adventure travel is becoming more popular, increasing the likelihood of contact with unusual pathogens. We investigated an outbreak of leptospirosis in “Eco-Challenge” multisport race athletes to determine illness etiology and implement public health measures. Of 304 athletes, we contacted 189 (62%) from the United States and 26 other countries. Eighty (42%) athletes met our case definition. Twenty-nine (36%) case-patients were hospitalized; none died. Logistic regression showed swimming in the Segama River (relative risk [RR]=2.0; 95% confidence interval [CI]=1.3 to 3.1) to be an independent risk factor. Twenty-six (68%) of 38 case-patients tested positive for leptospiral antibodies. Taking doxycycline before or during the race was protective (RR=0.4, 95% CI=0.2 to 1.2) for the 20 athletes who reported using it. Increased adventure travel may lead to more frequent exposure to leptospires, and preexposure chemoprophylaxis for leptospirosis (200 mg oral doxycycline/week) may decrease illness risk. Efforts are needed to inform adventure travel participants of unique infections such as leptospirosis.
Journal of Clinical Microbiology | 2006
Roger E. Morey; Renee L. Galloway; Sandra L. Bragg; Arnold G. Steigerwalt; Leonard W. Mayer; Paul N. Levett
ABSTRACT The genus Leptospira is classified into 13 named species and 4 genomospecies based upon DNA-DNA reassociation studies. Phenotypic tests are unable to distinguish between species of Leptospira, and there is a need for a simplified molecular approach to the identification of leptospires. 16S rRNA gene sequences are potentially useful for species identification of Leptospira, but there are a large number of sequences of various lengths and quality in the public databases. 16S rRNA gene sequences of near full length and bidirectional high redundancy were determined for all type strains of the species of the Leptospiraceae. Three clades were identified within the genus Leptospira, composed of pathogenic species, nonpathogenic species, and another clade of undetermined pathogenicity with intermediate 16S rRNA gene sequence relatedness. All type strains could be identified by 16S rRNA gene sequences, but within both pathogenic and nonpathogenic clades as few as two or three base pairs separated some species. Sequences within the nonpathogenic clade were more similar, and in most cases ≤10 bp distinguished these species. These sequences provide a reference standard for identification of Leptospira species and confirm previously established relationships within the genus. 16S rRNA gene sequencing is a powerful method for identification in the clinical laboratory and offers a simplified approach to the identification of Leptospira species.
Emerging Infectious Diseases | 2002
Barun K. De; Sandra L. Bragg; Gary N. Sanden; Kathy E. Wilson; Lois Diem; Chung K. Marston; Alex R. Hoffmaster; Gwen A. Barnett; Robbin S. Weyant; Teresa G. Abshire; John W. Ezzell; Tanja Popovic
A two-component direct fluorescent-antibody (DFA) assay, using fluorescein-labeled monoclonal antibodies specific to the Bacillus anthracis cell wall (CW-DFA) and capsule (CAP-DFA) antigens, was evaluated and validated for rapid identification of B. anthracis. We analyzed 230 B. anthracis isolates; 228 and 229 were positive by CW-DFA and CAP-DFA assays, respectively. We also tested 56 non–B. anthracis strains; 10 B. cereus and 2 B. thuringiensis were positive by the CW-DFA assay, and 1 B. megaterium strain was positive by CAP-DFA. Analysis of the combined DFA results identified 227 of 230 B. anthracis isolates; all 56 strains of the other Bacillus spp. were negative. Both DFA assays tested positive on 14 of 26 clinical specimens from the 2001 anthrax outbreak investigation. The two-component DFA assay is a sensitive, specific, and rapid confirmatory test for B. anthracis in cultures and may be useful directly on clinical specimens.
Applied and Environmental Microbiology | 2005
Chung K. Marston; Alex R. Hoffmaster; Kathy E. Wilson; Sandra L. Bragg; Brian D. Plikaytis; Philip S. Brachman; Scott E. Johnson; Arnold F. Kaufmann; Tanja Popovic
ABSTRACT The plasmid profiles of 619 cultures of Bacillus anthracis which had been isolated and stored between 1954 and 1989 were analyzed using the Laboratory Response Network real-time PCR assay targeting a chromosomal marker and both virulence plasmids (pXO1 and pXO2). The cultures were stored at ambient temperature on tryptic soy agar slants overlaid with mineral oil. When data were stratified by decade, there was a decreasing linear trend in the proportion of strains containing both plasmids with increased storage time (P < 0.001). There was no significant difference in the proportion of strains containing only pXO1 or strains containing only pXO2 (P = 0.25), but there was a statistical interdependence between the two plasmids (P = 0.004). Loss of viability of B. anthracis cultures stored on agar slants is also discussed.
American Journal of Tropical Medicine and Hygiene | 1999
Eduard J. Sanders; José G. Rigau-Pérez; H L Smits; C.C. Deseda; V A Vorndam; T. Aye; Richard A. Spiegel; R S Weyant; Sandra L. Bragg
American Journal of Tropical Medicine and Hygiene | 2000
Waraluk Tangkanakul; Piyanit Tharmaphornpil; Brian D. Plikaytis; Sandra L. Bragg; Duangporn Poonsuksombat; Pravit Choomkasien; Darika Kingnate; David A. Ashford
Journal of Clinical Microbiology | 1999
Henk L. Smits; Yulia V. Ananyina; Annette Chereshsky; Louella Dancel; Rudy F. M. Lai-a-Fat; Howard D. Chee; Paul N. Levett; Toshiyuki Masuzawa; Yasutake Yanagihara; M. A. Muthusethupathi; Eduard J. Sanders; David M. Sasaki; Harry Y. Domen; Claude Yersin; Tin Aye; Sandra L. Bragg; George C. Gussenhoven; Marga G. A. Goris; W. J. Terpstra; Rudy A. Hartskeerl
Javma-journal of The American Veterinary Medical Association | 2000
Enzo R. Campagnolo; Marion C. Warwick; Harvey L. Marx; Ross P. Cowart; H. Denny Donnell; Mary D. Bajani; Sandra L. Bragg; J.Emilio Esteban; David P. Alt; Jordan W. Tappero; Carole A. Bolin; David A. Ashford